Cohance Lifesciences Ltd header image

Cohance Lifesciences Ltd

543064

Equity

ISIN INE03QK01018 / Valor 46346459

Bombay Stock Exchange Ltd. (Mumbai) (2026-08-03)
INR 425.00-0.01%

Cohance Lifesciences Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Cohance Lifesciences Ltd is an India-based pharmaceutical company that operates as a contract development and manufacturing organization (CDMO), focusing on the development and commercial manufacture of small-molecule active pharmaceutical ingredients (APIs), intermediates and finished dosage forms. The firm provides process development, custom synthesis, scale‑up and commercial production services for domestic and export customers, positioning itself to support pharmaceutical companies through the transition from laboratory-scale chemistry to regulated commercial manufacturing. Its business is driven by contract manufacturing revenue, product sales and development fees, with competitive differentiation depending on technical know‑how, cost‑efficient production and compliance with regulatory quality standards in target markets.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-56.7%1Y
-13.1%3Y
-24.5%5Y

Performance

50.0%1Y
41.2%3Y
36.8%5Y

Volatility

Market cap

1711 M

Market cap (USD)

Daily traded volume (Shares)

550,589

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.48%USD 63.76
RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 12.90
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.24%USD 65.47
Zoetis Inc
Zoetis Inc Zoetis Inc Valor: 19276994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%USD 77.10
HCA Healthcare Inc
HCA Healthcare Inc HCA Healthcare Inc Valor: 11321027
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.00%USD 406.61
Takeda Yakuhin Kogyo KK
Takeda Yakuhin Kogyo KK Takeda Yakuhin Kogyo KK Valor: 11292411
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.52%USD 16.83
Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.20%USD 88.82
Merck & Co Inc
Merck & Co Inc Merck & Co Inc Valor: 10683053
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.87%USD 127.77
Cencora Inc
Cencora Inc Cencora Inc Valor: 1212868
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%USD 308.37
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.42%USD 28.10